EPIZYME
Live / Registered — Registered (as of 08 Nov 2022)
What this means for you
Registered since 08 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88452418
- Registration number
- 6895603
- Mark type
- Stylized text
- Filed
- 30 May 2019
- Published for opposition
- 21 Apr 2020
- Registered
- 08 Nov 2022
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the treatment of human diseases and disorders, namely, genetic diseases and disorders
Owner
- Epizyme, Inc., Cambridge, MA, US
- Epizyme, Inc., Cambridge, MA, US
- Epizyme, Inc., Cambridge, MA, US
Prosecution history
- 08 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Oct 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 05 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 27 May 2022 — USE AMENDMENT FILED
- 27 May 2022 — TEAS STATEMENT OF USE RECEIVED
- 08 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2021 — SOU EXTENSION 3 GRANTED
- 06 Dec 2021 — SOU EXTENSION 3 FILED
- 06 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 04 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2021 — SOU EXTENSION 2 GRANTED
- 16 Jun 2021 — SOU EXTENSION 2 FILED